Anagenex is a company focused on accelerating drug discovery using advanced AI technology and large-scale data. By testing billions of molecules and generating high-quality datasets, Anagenex leverages proprietary neural networks to design and refine new compounds that can potentially treat diseases more efficiently. The company aims to overcome the traditional 25-year timeline from disease protein identification to medicinal application, integrating iterative AI and real laboratory experiments to speed up the process, thereby bringing medicines to patients faster.